WHO ICTRP trial
Pharmacokinetic interaction between hydronidone capsule and Entecavir capsule in…
ChiCTR2200059683 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200059683 |
|---|---|
| Public title | Pharmacokinetic interaction between hydronidone capsule and Entecavir capsule in Healthy Chinese subjects |
| Scientific title | Pharmacokinetic interaction between hydronidone capsule and Entecavir capsule in Healthy Chinese subjects(single center, random, open, self control) |
| Primary sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Not applicable |
| Interventions | Fasting administration group:Day 1 to 6: at about 07:30, 15:30, 23:30, take 60mg (2 tablets) of hydroxynitone capsule on an empty stomach with 200mL water; Day 7: Take 60mg (2 tablets) of hydroxynitone capsule orally on an empty stomach… |
| Registration date | May 7, 2022 |
| Target size | Fasting administration group:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: